You are using an outdated browser. For a faster, safer browsing experience, upgrade for free today.

Medical Care

Global Circadian Rhythm Sleep Disorders Market Research Report 2021, Competitive Analysis, Industry Growth Trends And Forecast 2027

Market Analysis and Insights: Global Circadian Rhythm Sleep Disorders Market
The research report studies the Circadian Rhythm Sleep Disorders market using different methodologies and analyzes to provide accurate and in-depth information about the market. For a clearer understanding, it is divided into several parts to cover different aspects of the market. Each area is then elaborated to help the reader comprehend the growth potential of each region and its contribution to the global market. The researchers have used primary and secondary methodologies to collate the information in the report. They have also used the same data to generate the current market scenario. This report is aimed at guiding people towards an apprehensive, better, and clearer knowledge of the market.
The global Circadian Rhythm Sleep Disorders market size is projected to reach US$ 1104.6 million by 2027, from US$ 844 million in 2020, at a CAGR of 4.2% during 2021-2027.
Global Circadian Rhythm Sleep Disorders Scope and Segment
The global Circadian Rhythm Sleep Disorders market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Circadian Rhythm Sleep Disorders market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type, and by Application for the period 2016-2027.
by Type, the market is primarily split into
Delayed Sleep Phase Disorder (DSP)
Jet Lag Disorder
Irregular Sleep-Wake Rhythm
Free-Running (nonentrained) Type
Shift Work Disorder
Advanced Sleep Phase Disorder (ASP)
by Application, this report covers the following segments
Hospitals
Sleep Centers
Home Care Settings
Global Circadian Rhythm Sleep Disorders market: regional analysis, the major regions covered in the report are:
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of Middle East & Africa
The report lists the major players in the regions and their respective market share on the basis of global revenue. It also explains their strategic moves in the past few years, investments in product innovation, and changes in leadership to stay ahead in the competition. This will give the reader an edge over others as a well-informed decision can be made looking at the holistic picture of the market.
The Circadian Rhythm Sleep Disorders key players in this market include:
Arena Pharmaceuticals
Boehringer Ingelheim
Fabre-Kramer Pharmaceuticals
Jazz Pharmaceuticals
Merck & Co
Glaxo Smith Kline
Respirerx Pharmaceuticals
Neurocrine Biosciences
1 Market Overview of Circadian Rhythm Sleep Disorders
1.1 Circadian Rhythm Sleep Disorders Market Overview
1.1.1 Circadian Rhythm Sleep Disorders Product Scope
1.1.2 Circadian Rhythm Sleep Disorders Market Status and Outlook
1.2 Global Circadian Rhythm Sleep Disorders Market Size Overview by Region 2016 VS 2021VS 2027
1.3 Global Circadian Rhythm Sleep Disorders Market Size by Region (2016-2027)
1.4 Global Circadian Rhythm Sleep Disorders Historic Market Size by Region (2016-2021)
1.5 Global Circadian Rhythm Sleep Disorders Market Size Forecast by Region (2022-2027)
1.6 Key Regions, Circadian Rhythm Sleep Disorders Market Size (2016-2027)
1.6.1 North America Circadian Rhythm Sleep Disorders Market Size (2016-2027)
1.6.2 Europe Circadian Rhythm Sleep Disorders Market Size (2016-2027)
1.6.3 Asia-Pacific Circadian Rhythm Sleep Disorders Market Size (2016-2027)
1.6.4 Latin America Circadian Rhythm Sleep Disorders Market Size (2016-2027)
1.6.5 Middle East & Africa Circadian Rhythm Sleep Disorders Market Size (2016-2027)
2 Circadian Rhythm Sleep Disorders Market Overview by Type
2.1 Global Circadian Rhythm Sleep Disorders Market Size by Type: 2016 VS 2021 VS 2027
2.2 Global Circadian Rhythm Sleep Disorders Historic Market Size by Type (2016-2021)
2.3 Global Circadian Rhythm Sleep Disorders Forecasted Market Size by Type (2022-2027)
2.4 Delayed Sleep Phase Disorder (DSP)
2.5 Jet Lag Disorder
2.6 Irregular Sleep-Wake Rhythm
2.7 Free-Running (nonentrained) Type
2.8 Shift Work Disorder
2.9 Advanced Sleep Phase Disorder (ASP)
3 Circadian Rhythm Sleep Disorders Market Overview by Application
3.1 Global Circadian Rhythm Sleep Disorders Market Size by Application: 2016 VS 2021 VS 2027
3.2 Global Circadian Rhythm Sleep Disorders Historic Market Size by Application (2016-2021)
3.3 Global Circadian Rhythm Sleep Disorders Forecasted Market Size by Application (2022-2027)
3.4 Hospitals
3.5 Sleep Centers
3.6 Home Care Settings
4 Circadian Rhythm Sleep Disorders Competition Analysis by Players
4.1 Global Circadian Rhythm Sleep Disorders Market Size by Players (2016-2021)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Circadian Rhythm Sleep Disorders as of 2020)
4.3 Date of Key Players Enter into Circadian Rhythm Sleep Disorders Market
4.4 Global Top Players Circadian Rhythm Sleep Disorders Headquarters and Area Served
4.5 Key Players Circadian Rhythm Sleep Disorders Product Solution and Service
4.6 Competitive Status
4.6.1 Circadian Rhythm Sleep Disorders Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles and Key Data
5.1 Arena Pharmaceuticals
5.1.1 Arena Pharmaceuticals Profile
5.1.2 Arena Pharmaceuticals Main Business
5.1.3 Arena Pharmaceuticals Circadian Rhythm Sleep Disorders Products, Services and Solutions
5.1.4 Arena Pharmaceuticals Circadian Rhythm Sleep Disorders Revenue (US$ Million) & (2016-2021)
5.1.5 Arena Pharmaceuticals Recent Developments
5.2 Boehringer Ingelheim
5.2.1 Boehringer Ingelheim Profile
5.2.2 Boehringer Ingelheim Main Business
5.2.3 Boehringer Ingelheim Circadian Rhythm Sleep Disorders Products, Services and Solutions
5.2.4 Boehringer Ingelheim Circadian Rhythm Sleep Disorders Revenue (US$ Million) & (2016-2021)
5.2.5 Boehringer Ingelheim Recent Developments
5.3 Fabre-Kramer Pharmaceuticals
5.3.1 Fabre-Kramer Pharmaceuticals Profile
5.3.2 Fabre-Kramer Pharmaceuticals Main Business
5.3.3 Fabre-Kramer Pharmaceuticals Circadian Rhythm Sleep Disorders Products, Services and Solutions
5.3.4 Fabre-Kramer Pharmaceuticals Circadian Rhythm Sleep Disorders Revenue (US$ Million) & (2016-2021)
5.3.5 Jazz Pharmaceuticals Recent Developments
5.4 Jazz Pharmaceuticals
5.4.1 Jazz Pharmaceuticals Profile
5.4.2 Jazz Pharmaceuticals Main Business
5.4.3 Jazz Pharmaceuticals Circadian Rhythm Sleep Disorders Products, Services and Solutions
5.4.4 Jazz Pharmaceuticals Circadian Rhythm Sleep Disorders Revenue (US$ Million) & (2016-2021)
5.4.5 Jazz Pharmaceuticals Recent Developments
5.5 Merck & Co
5.5.1 Merck & Co Profile
5.5.2 Merck & Co Main Business
5.5.3 Merck & Co Circadian Rhythm Sleep Disorders Products, Services and Solutions
5.5.4 Merck & Co Circadian Rhythm Sleep Disorders Revenue (US$ Million) & (2016-2021)
5.5.5 Merck & Co Recent Developments
5.6 Glaxo Smith Kline
5.6.1 Glaxo Smith Kline Profile
5.6.2 Glaxo Smith Kline Main Business
5.6.3 Glaxo Smith Kline Circadian Rhythm Sleep Disorders Products, Services and Solutions
5.6.4 Glaxo Smith Kline Circadian Rhythm Sleep Disorders Revenue (US$ Million) & (2016-2021)
5.6.5 Glaxo Smith Kline Recent Developments
5.7 Respirerx Pharmaceuticals
5.7.1 Respirerx Pharmaceuticals Profile
5.7.2 Respirerx Pharmaceuticals Main Business
5.7.3 Respirerx Pharmaceuticals Circadian Rhythm Sleep Disorders Products, Services and Solutions
5.7.4 Respirerx Pharmaceuticals Circadian Rhythm Sleep Disorders Revenue (US$ Million) & (2016-2021)
5.7.5 Respirerx Pharmaceuticals Recent Developments
5.8 Neurocrine Biosciences
5.8.1 Neurocrine Biosciences Profile
5.8.2 Neurocrine Biosciences Main Business
5.8.3 Neurocrine Biosciences Circadian Rhythm Sleep Disorders Products, Services and Solutions
5.8.4 Neurocrine Biosciences Circadian Rhythm Sleep Disorders Revenue (US$ Million) & (2016-2021)
5.8.5 Neurocrine Biosciences Recent Developments
6 North America
6.1 North America Circadian Rhythm Sleep Disorders Market Size by Country (2016-2027)
6.2 United States
6.3 Canada
7 Europe
7.1 Europe Circadian Rhythm Sleep Disorders Market Size by Country (2016-2027)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Circadian Rhythm Sleep Disorders Market Size by Region (2016-2027)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Circadian Rhythm Sleep Disorders Market Size by Country (2016-2027)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Circadian Rhythm Sleep Disorders Market Size by Country (2016-2027)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Circadian Rhythm Sleep Disorders Market Dynamics
11.1 Circadian Rhythm Sleep Disorders Industry Trends
11.2 Circadian Rhythm Sleep Disorders Market Drivers
11.3 Circadian Rhythm Sleep Disorders Market Challenges
11.4 Circadian Rhythm Sleep Disorders Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Au
  • FORMAT: PDF
  • PUBLISHED DATE: Apr, 2021
  • NO OF PAGES: 125